Literature DB >> 30108873

Synthesis, molecular modeling and biological evaluation of aza-flavanones as α-glucosidase inhibitors.

Sivaprasad Kasturi1,2, Sujatha Surarapu1, Chandra Chary Bathoju1, Srinivas Uppalanchi1, Shubham Dwivedi3, Yogeeswari Perumal3, Dilep Kumar Sigalapalli4, Bathini Nagendra Babu4, Krishna S Ethiraj1, Jaya Shree Anireddy2.   

Abstract

An efficient acid catalyzed methodology has been employed to synthesize a variety of aza-flavanones and their α-glucosidase inhibitory activity is evaluated using acarbose, miglitol and voglibose as reference standards. Molecular modeling studies were performed for all compounds to identify the important binding modes responsible for the inhibition activity of α-glucosidase which helped find key interactions between the enzyme and the active compounds. Among all the compounds 5g, 5r and 5w have shown high α-glucosidase inhibition activity compared to standard reference drugs and have been identified as promising potential antidiabetic agents. This study is the first biological evaluation of aza-flavanones as α-glucosidase inhibitors.

Entities:  

Year:  2017        PMID: 30108873      PMCID: PMC6072087          DOI: 10.1039/c7md00162b

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  14 in total

1.  aza-Flavanones as potent cross-species microRNA inhibitors that arrest cell cycle.

Authors:  Srivari Chandrasekhar; Sreerangam N C V L Pushpavalli; Srinivas Chatla; Debasmita Mukhopadhyay; Bogonda Ganganna; Kandi Vijeender; Pabbaraja Srihari; Chada Raji Reddy; M Janaki Ramaiah; Utpal Bhadra
Journal:  Bioorg Med Chem Lett       Date:  2011-10-24       Impact factor: 2.823

2.  Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.

Authors:  Woo Duck Seo; Jin Hyo Kim; Jae Eun Kang; Hyung Won Ryu; Marcus J Curtis-Long; Hyun Sun Lee; Min Suk Yang; Ki Hun Park
Journal:  Bioorg Med Chem Lett       Date:  2005-10-03       Impact factor: 2.823

3.  Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.

Authors:  Chi-Chih Chang; Sheau Ling Ho; Shoei-Sheng Lee
Journal:  Bioorg Med Chem       Date:  2015-05-05       Impact factor: 3.641

4.  Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis.

Authors:  S X Zhang; J Feng; S C Kuo; A Brossi; E Hamel; A Tropsha; K H Lee
Journal:  J Med Chem       Date:  2000-01-27       Impact factor: 7.446

5.  Crystal structures of isomaltase from Saccharomyces cerevisiae and in complex with its competitive inhibitor maltose.

Authors:  Keizo Yamamoto; Hideo Miyake; Masami Kusunoki; Shigeyoshi Osaki
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

6.  Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents.

Authors:  Y Xia; Z Y Yang; P Xia; K F Bastow; Y Tachibana; S C Kuo; E Hamel; T Hackl; K H Lee
Journal:  J Med Chem       Date:  1998-03-26       Impact factor: 7.446

7.  Voglibose: an alpha glucosidase inhibitor.

Authors:  Ajay S Dabhi; Nikita R Bhatt; Mohit J Shah
Journal:  J Clin Diagn Res       Date:  2013-12-15

8.  Aromatic nucleophilic substitution or CuI-catalyzed coupling route to martinellic acid.

Authors:  Dawei Ma; Chengfeng Xia; Jiqing Jiang; Jianhua Zhang; Wenjun Tang
Journal:  J Org Chem       Date:  2003-01-24       Impact factor: 4.354

Review 9.  3-Hydroxy-2-phenyl-4(1H)-quinolinones as promising biologically active compounds.

Authors:  P Hradil; J Hlavác; M Soural; M Hajdúch; M Kolár; R Vecerová
Journal:  Mini Rev Med Chem       Date:  2009-06       Impact factor: 3.862

10.  Solvent-dependent diastereoselectivities in reductions of beta-hydroxyketones by SmI2.

Authors:  Pramod R Chopade; Todd A Davis; Edamana Prasad; Robert A Flowers
Journal:  Org Lett       Date:  2004-08-05       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.